Published: Aug, 2016
The global mouth ulcers treatment market is highly fragmented due to the presence of numerous local and international players competing for a higher share in the revenue pie. However, the market is characterized by the dominance of a handful of players, namely 3M Health Care, ECR Pharmaceuticals, Church & Dwight Co. Inc., Bristol-Myer Squibb Company, and GlaxoSmithKline plc, states Transparency Market Research (TMR) in a new report.
A TMR analyst points out, “Research and development for product development is one of the key growth strategies that leading companies in this market are focused on.” The objective of these efforts is to deliver value to consumers in the near as well as long term. The R&D activities of top companies such as Pfizer are also focused on improving the effectiveness of existing products and discovering newer indications for mouth ulcers.
The global mouth ulcers treatment market is expected to reach a valuation of US$1,596.9 mn by 2020. On the basis of formulation, gels led with 58.31% of the global market in 2013. This is mainly due to the easy availability of gels in pharmacies and rising preference of healthcare professionals for these products. However, the lozenges segment is expected to display the highest growth rate in the coming years. North America led with 40% of the global mouth ulcers treatment market in 2013. This is attributed to the high prevalence of mouth ulcers and the high level of awareness about treatments for mouth ulcers.
Branding Activities to Raise Awareness about Mouth Ulcers Favor Market Growth
Increasing awareness about mouth ulcers is one of the primary factors propelling the global mouth ulcers treatment market. The extensive promotional and branding activities carried out by market players is leading to an increased awareness about mouth ulcers in the global population. This, in turn, is leading to an increased uptake of mouth ulcers treatment products.
An increasing aging population is propelling the demand for mouth ulcers treatment products globally. The favorable healthcare reforms in the U.S. and the U.K. have led to an increased life expectancy of the population. However, elderly people are more prone to infections, which also include mouth ulcers. This is leading to an increased demand for mouth ulcer treatment products. According to estimates from the U.S. Census Bureau, there will be almost 89 million people above the age of 65 years by 2050. Thus, the exponential rise in geriatric population will augment the demand for mouth ulcers treatment products in the country.
Risk of Side-effects Leads to Reluctance for Mouth Ulcer Treatment Products
“The side effects of mouth ulcers treatment products pose a threat to the market’s growth,” says a TMR analyst. The side effects of mouth ulcers treatment products range from mild to severe, which include headache, vomiting, and loss of consciousness. Due to the significant side effects of a few products, they are not approved to be administered to children in the U.S. Thus, mouth ulcers patients are not willing to take prescription medication for treatment, and often opt for home remedies. This is restraining the market’s growth. To overcome these restraints, mergers and acquisitions for a wider product portfolio is what key companies in the global mouth ulcers market are focusing on.
The information presented in this review is based on a Transparency Market Research report, titled “Mouth Ulcers Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
The global mouth ulcers treatment market is segmented as follows:
Mouth Ulcers Treatment Market, by Formulation
Mouth Ulcers Treatment Market, by Indication
- Aphthous Stomatitis
- Oral Lichen Planus
Mouth Ulcers Treatment Market, by Drug Class
Mouth Ulcers Treatment Market, by Geography
- North America
- Rest of the World
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453